Efficient delivery of small interfering RNA (siRNA) remains the greatest technological barrier to the clinical implementation of RNA interference strategies. We are investigating the relationship between the biophysical properties of siRNA nanocomplexes and their transfection efficiency as an approach to the generation of improved formulations. Peptide-based formulations are of great interest, and so in this study we have compared nanocomplex formulations for siRNA delivery containing linear and branched oligolysine or oligoarginine peptides. Peptides were combined with cationic liposomes in siRNA formulations and compared for transfection efficiency, siRNA packaging efficiency, biophysical properties, and particle stability. Nanocomplexes ...
Therapeutic RNAs, especially siRNAs, are a promising approach for treating diseases like cancer, neu...
Therapeutic RNAs, especially siRNAs, are a promising approach for treating diseases like cancer, neu...
Nucleic acid therapeutics involves the use of polynucleotides (DNA, RNA) as novel therapeutic agents...
Ternary nanocomplexes, composed of bifunctional cationic peptides, lipids and siRNA, as delivery veh...
Introduction: The field of RNA interference technology has been researched extensively in recent yea...
Delivery of small interfering RNA (siRNA) as a therapeutic tool is limited due to critical obstacles...
<div><p>We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising d...
We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising different...
Synthetic short interfering RNA (siRNA) oligonucleotides can trigger the RNA interference pathway an...
Because nanoparticles with diameters less than 50 nm penetrate stromal-rich tumor tissues more effic...
Cell-penetrating peptides (CPPs) are short cationic peptides that have been extensively studied as d...
International audienceAbstract Recently, we designed novel amphipathic cell-penetrating peptides, ca...
Aristides D Tagalakis,1,* Sara Castellaro,1,2,* Haiyan Zhou,1 Alison Bienemann,3 Mustafa M Munye,1 D...
International audienceAbstract Recently, we designed novel amphipathic cell-penetrating peptides, ca...
Abstract Recently, we designed novel amphipathic cell-penetrating peptides, called WRAP, able to tra...
Therapeutic RNAs, especially siRNAs, are a promising approach for treating diseases like cancer, neu...
Therapeutic RNAs, especially siRNAs, are a promising approach for treating diseases like cancer, neu...
Nucleic acid therapeutics involves the use of polynucleotides (DNA, RNA) as novel therapeutic agents...
Ternary nanocomplexes, composed of bifunctional cationic peptides, lipids and siRNA, as delivery veh...
Introduction: The field of RNA interference technology has been researched extensively in recent yea...
Delivery of small interfering RNA (siRNA) as a therapeutic tool is limited due to critical obstacles...
<div><p>We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising d...
We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising different...
Synthetic short interfering RNA (siRNA) oligonucleotides can trigger the RNA interference pathway an...
Because nanoparticles with diameters less than 50 nm penetrate stromal-rich tumor tissues more effic...
Cell-penetrating peptides (CPPs) are short cationic peptides that have been extensively studied as d...
International audienceAbstract Recently, we designed novel amphipathic cell-penetrating peptides, ca...
Aristides D Tagalakis,1,* Sara Castellaro,1,2,* Haiyan Zhou,1 Alison Bienemann,3 Mustafa M Munye,1 D...
International audienceAbstract Recently, we designed novel amphipathic cell-penetrating peptides, ca...
Abstract Recently, we designed novel amphipathic cell-penetrating peptides, called WRAP, able to tra...
Therapeutic RNAs, especially siRNAs, are a promising approach for treating diseases like cancer, neu...
Therapeutic RNAs, especially siRNAs, are a promising approach for treating diseases like cancer, neu...
Nucleic acid therapeutics involves the use of polynucleotides (DNA, RNA) as novel therapeutic agents...